SCHEMBL801486

SCHEMBL801486

CC(C)(C)c1ccc2cc(P(=O)(c3ccccc3)c3ccc4c(c3)c3ccccc3n4-c3ccc(P(=O)(c4ccccc4)c4ccccc4)cc3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 8/20 0.40
▸ PPARA Q07869 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ PGR P06401 1/20 0.35
▸ RORA P35398 1/20 0.35
▸ RORC P51449 1/20 0.35
▸ RORB Q92753 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ PTGES O14684 1/20 0.34
▸ KCNH2 Q12809 1/20 0.33
▸ DNMT1 P26358 3/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801740 0.98 KDM4E (0.41) PPARGPPARAKDM4EATML3MBTL1
SCHEMBL801165 0.96 PPARG (0.38) PPARGPPARAKDM4ENPSR1PGR
SCHEMBL801604 0.91 PPARG (0.38) PPARGPPARAKDM4EATML3MBTL1
SCHEMBL801721 0.90 PPARG (0.42) PPARGPPARAKDM4EATML3MBTL1
SCHEMBL801164 0.88 PPARG (0.41) PPARGPPARAKDM4ENPSR1PGR
SCHEMBL801133 0.86 KDM4E (0.47) KDM4EATML3MBTL1NPSR1PGR
SCHEMBL801335 0.86 PPARG (0.39) PPARGPPARAKDM4ENPSR1PGR
SCHEMBL801175 0.85 KDM4E (0.52) KDM4EATML3MBTL1NPSR1PGR
SCHEMBL29512004 0.85 KDM4E (0.52) KDM4EATML3MBTL1NPSR1PGR
SCHEMBL801600 0.84 PPARG (0.39) PPARGPPARAKDM4ENPSR1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 PPARG 1500/4885PPARA 1218/4885KDM4E 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback